AI Verdict
Both stocks have similar AI ratings. Review detailed metrics below.
RMAX vs RLYB Fundamental Comparison
| Metric | RMAX | RLYB |
|---|---|---|
| Revenue | $291.6M | $858,000.0 |
| Net Income | $8.2M | $-9.0M |
| Net Margin | 2.8% | -1,046.4% |
| ROE | 1.8% | -15.5% |
| ROA | 1.4% | -14.4% |
| Current Ratio | 1.69x | 14.50x |
| Debt/Equity | 0.96x | 0.00x |
| EPS | $0.60 | $-1.59 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
RMAX vs RLYB: Frequently Asked Questions
Is RMAX or RLYB a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), both stocks have similar ratings. RMAX is rated SELL (72% confidence) while RLYB is rated SELL (72% confidence). This is not investment advice.
How does RMAX compare to RLYB fundamentally?
RE/MAX Holdings, Inc. has ROE of 1.8% vs Rallybio Corp's -15.5%. Net margins are 2.8% vs -1,046.4% respectively.
Which stock pays higher dividends, RMAX or RLYB?
RMAX has a dividend yield of N/A or no dividend while RLYB has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in RMAX or RLYB for long term?
For long-term investing, consider that RMAX has SELL rating with 72% confidence, while RLYB has SELL rating with 72% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about RMAX vs RLYB?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For RMAX vs RLYB, both AIs rate them similarly based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.